Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.00114 USD | -28.75% | -26.67% | -87.36% |
2023 | Endonovo Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
2023 | Endonovo Therapeutics, Inc 's Sofpulse® Secures Taiwan FDA Approval | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
398K | - | - | - | - | - | |
115B | ||||||
106B | ||||||
21.96B | - | |||||
21.87B | - | |||||
19.21B |